Curcumin Modulates Platelet Activation and ROS Production Induced by Amyloid Peptides: New Perspectives in Attenuating Prothrombotic Risk in Alzheimer’s Disease Patients
2024

Curcumin and Platelet Activation in Alzheimer's Disease

publication Evidence: moderate

Author Information

Author(s): Rustichelli Serena, Lanni Cristina, Zarà Marta, Guidetti Gianni Francesco, Torti Mauro, Canobbio Ilaria

Primary Institution: University of Pavia

Hypothesis

Can curcumin modulate platelet activation induced by amyloid peptides in Alzheimer's disease patients?

Conclusion

Curcumin effectively suppresses platelet aggregation induced by amyloid peptides, indicating its potential as a treatment to reduce cardiovascular risks in Alzheimer's disease patients.

Supporting Evidence

  • Curcumin suppressed platelet aggregation induced by fibrillar amyloid peptides.
  • Curcumin reduced reactive oxygen species production in platelets stimulated by amyloid peptides.
  • Curcumin displayed selective inhibitory activity on platelet responses to pathological stimuli.

Takeaway

Curcumin, a natural compound, helps stop blood cells called platelets from getting too excited when they see certain bad proteins linked to Alzheimer's, which could help keep hearts healthy.

Methodology

The study used isolated human platelets to analyze the effects of curcumin on platelet aggregation, granule secretion, and reactive oxygen species production.

Limitations

The study's findings may be limited by curcumin's poor bioavailability and the need for further in vivo investigations.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/nu16244419

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication